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This study investigated a potential independent associationbetween hypovitaminosisD and suspected nonalcoholicfatty liver dis-
ease (NAFLD) in a nationally representative sample of the US adolescents. Data from 1630 subjects 12–19years of age were exam-
ined using the National Health and Nutrition Examination Survey, 2001–2004. The vitamin D status of subjects was categorized
into quartiles of serum 25-hydroxyvitamin D. Subjects with serum ALT > 30U/L were classiﬁed as havingsuspected NAFLD. Data
regarding age, sex, race, BMI, and poverty level were also analyzed in bivariate and multivariate analyses using SAS and SUDAAN
software. Suspected NAFLD was identiﬁed in 12.1% of adolescents in the lowest quartile compared to 6.9% of adolescents in the
second quartile, 8.0% in the third quartile, and 13.17% in the highest quartile of serum 25(OH)D concentrations (P = .05). In
analysesutilizingvitaminD asa continuous variable, noindependent associationwasfound between VitaminD levels andrates of
elevatedALTlevels.Inmultivariateanalyses,higherrisksforsuspected NAFLDwere observedinmalesandoverweight adolescents;
however, vitamin D status was not found to be independently associated with suspected NAFLD after adjusting for obesity.
1.Introduction
Vitamin D deﬁciency has been classically associated with
ricketsinchildhoodandosteomalaciainadults.However,the
vitamin D receptor is ubiquitous, and the study of the physi-
ologic roles of vitamin D has revealed health consequences
of poor vitamin D status that extend beyond the skeletal
system [1]. Vitamin D has been found to have a potential
role in autoimmune and inﬂammatory processes, and there
is agrowing literature that suggeststhat lowvitamin D status
may contribute to the development of insulin resistance,
hypertension, and the metabolic syndrome (MS) [2–7].
Evidence from randomized, placebo-controlled trials also
suggests that vitamin D supplementation eﬀectively reduces
insulin resistance [8, 9].
Serum 25-hydroxyvitamin D3, produced by the hydrox-
ylation of vitamin D3 (cholecalciferol) in the liver, reﬂects
body stores of vitamin D. Over the past two decades, serum
25(OH)D concentrations have markedly decreased in the
general US population. Only 23% of children and adults
were considered to be vitamin D suﬃcient (serum 25(OH)D
≥30mg/L) according to national data from 2001 to 2004,
as compared to 45% in 1988–1994 [10]. Additionally, over
the past 3 decades, the prevalence of childhood obesity
has increased, and with that has come a parallel increase
in obesity-related sequelae such as non-alcoholic fatty liver
disease(NAFLD)[11,12].NAFLDisthemost commonform
of liver disease in the pediatric population, with a prevalence
of8.0%(asdeﬁnedbyALT > 30U/L)among12–19-yearolds
[13].NAFLDisalsomorecommonamongthosewithgreater
adiposity and elevated fasting insulin levels.
With a rise in the number of overweight children and
adolescents, it is important to consider the implications of
poor vitamin D status on the development and progression2 Journal of Obesity
of obesity and its comorbidities. Given the increasing preva-
lence of hypovitaminosis D and the increasing prevalence of
NAFLD, it is possible that there is an association between
low-vitamin D status and NAFLD. To our knowledge, no
previous study has examined the association between serum
25(OH)D concentrations and the presence of suggested
NAFLDin a large, nationally representative sample of the US
adolescent population. Previous smaller studies have investi-
gated the relationship between vitamin D status and NAFLD
in children and adults with conﬂicting results [14–16]. The
purpose ofthisstudy wasto utilize data froma national sam-
pletoinvestigatewhethersuspectedNAFLDisindependently
associated with hypovitaminosis D in adolescents.
2.Methods
Data were examined regarding 1630 individuals aged 12–19
years who participated in the National Health and Nutri-
tion Examination Survey (NHANES) from 2001 to 2004.
NHANES is an ongoing series of cross-sectional surveys
conducted by the National Center for Health Statistics of the
CentersforDisease Controland Prevention.Dataiscollected
from a nationally representative sample of the noninstitu-
tionalized civilian population in the USA. During a home
interview, participants provideinformation concerning fam-
ily medical history, current medical conditions, medication
use, and socioeconomic and demographic characteristics.
Additional data are collected from participants who are
randomly assigned to visit mobile examination centers.
Participants undergo a physical examination and laboratory
testing of blood and urine samples. Approximately 5000
individualsaresurveyedannually,andabouthalfarechildren
and adolescents.
The details of the measurement and analysis of ALT
concentrations and serum 25-hydroxyvitamin D in
NHANES have been previously described [7, 12]. Serum
25(OH)D reﬂects the vitamin D obtained from sunlight
exposure as well as from dietary intake [1]. The vitamin
D status of subjects was categorized into quartiles of
serum 25(OH) D in those analyses where vitamin D
was treated as a categorical variable: I (≤19ng/mL), II
(19ng/mL>serum(OH)D≤25ng/mL), III (25ng/mL> se-
rum(OH)D≤31ng/mL),andIV(>31ng/mL).Otherstudies
of the associations between hypovitaminosis D and
cardiovascular disease risk factors have used similar but not
identical values to assess vitamin D status; however, there is
no consensus for deﬁning hypovitaminosis D [6, 7, 13, 14].
Additionally, there is currently no consensus on optimal
concentrations of 25(OH)D as measured in serum [1]. Ado-
lescents with serum ALT ≥ 30U/L were classiﬁed as having
suspected NAFLD in analyses where vitamin D was treated
as a categorical variable. While the most accurate diagnosis
of NAFLD requires a biopsy, other observational studies also
use elevated concentrations of serum alanine aminotrans-
ferase as a surrogate marker for NAFLD [12, 15–17].
Data regarding age, sex, race, BMI, waist circumference,
and poverty level were also evaluated. Subjects with an
age- and gender-adjusted BMI>5th percentile and <85th
percentile were classiﬁed as normal weight; those with a
BMI≥85th but <95th percentile were classiﬁed as over-
weight; those with a BMI≥95th percentile were classiﬁed
as obese. Age- and gender- speciﬁc waist circumference
was categorized as <90th or >90th percentile. Race/ethnicity
was categorized as non-Hispanic white, non-Hispanic black,
Mexican American, or “other” (including multiracial or
other Hispanics).
The following exclusion criteria were applied to this
sample: (1) positive for hepatitis B or hepatitis C, (2)
pregnant, (3) adolescents who had not fasted for at least
6 hours, (4) type 1 diabetes (deﬁned as adolescents who
were taking insulin), (5) type 2 diabetes, (6) BMI<5th
percentile, (7) taking HMG-CoA reductase inhibitors or
valproic acid, two common medications that may cause
elevated ALT as a side eﬀect, and (8) adolescents with serum
iron concentrations >170 micrograms/dL. No information
regarding the time of year in which the measurements of
serum 25(OH)D or ALT were collected was available for
analysis in this study. Alcohol consumption was also not
recorded in the NHANES database for adolescents. None of
thesubjectsinthisstudywere takingvitaminDsupplements.
3.StatisticalAnalyses
When the serum 25(OH)D of subjects was categorized into
quartiles, the prevalence of suspected NAFLD in adolescents
was identiﬁed only by serum ALT ≥ 30. Bivariate and
multivariate analyses using SAS (version 8.2) and SUDAAN
(version 7.5) software were performed. In bivariate analyses
both BMI and waist circumference status were included and
independent T-tests were employed. Multivariate analyses,
included age, sex, race, adiposity (as measured by BMI),
and poverty status. All of the variables were included in
the multivariate logistic regression analysis to determine
independent associations with suspected NAFLD.
We repeated the analyses treating serum 25(OH)D as a
continuousvariable. The following multivariate modelswere
employed: (1) age, gender, race/ethnicity, BMI, and poverty
status, (2) age, gender, race/ethnicity, waist circumference,
and poverty status, and (3) age, gender, race/ethnicity, and
poverty status. F o re a c ho ft h e s em o d e l s ,w ea l s ou s e dt h r e e
diﬀerent thresholds of ALT to deﬁne suspected NAFLD,
including ALT ≥ 20, ALT ≥ 30, and ALT ≥ 40. Finally,
we conducted an additional bivariate analysis treating both
25(OH)D and ALT as continuous variables.
When serum 25(OH)D was treated as a continuous
variable, the prevalence of suspected NAFLD in adolescents
was identiﬁed using three diﬀerent thresholds of ALT,
including ALT ≥ 20, ALT ≥ 30, and ALT ≥ 40. Bivariate
and multivariate analyses were also conducted using SAS
(Version 8.2) and SUDAAN (Version 7.5) software to adjust
for age, sex, race, adiposity (as measured by BMI or waist
circumference), and poverty status. All of the variables
were included in multivariate logistic regression analyses to
determine independent associations with NAFLD.
Furthermore, as a continuous variable, correlation of
ALT with serum 25(OH)D was examined.Journal of Obesity 3
Table 1: Demographic and selected physical features and nonalcoholicfatty liver disease—NHANES 2001–2004: age 12–19∗.
N (unweighted) NAFLD (ALT ≥ 30), % P value
Age .10
12–15y 799 6.82
16–19y 831 9.88
Gender <.001
Male 853 13.70
Female 777 2.66
Race/ethnicity .05
Non-Hispanic White 449 8.23
Non-Hispanic Black 555 6.01
Mexican American 515 11.63
Other Hispanics 54 11.13
Other Races 57 5.77
BMI .001
Normal weight 1035 3.25
Overweight 284 9.03
Obese 311 25.76
Waist circumference above 90 percentile .003
Yes 891 14.18
No 739 3.14
Poverty .30
Yes 537 10.22
No 1023 8.18
25(OH)D quartile .05
I( ≤19ng/mL) 686 12.31
II (19ng/mL < serum[OH]D ≤ 25ng/mL) 452 6.91
III (25ng/mL < serum[OH]D ≤31 ng/mL) 297 6.81
IV (≥31ng/mL) 195 7.14
∗ALT and 25(OH)D values were available for 1630 individuals, and so each comparison has 1630 subjects, except as regards the analyses comparing poverty
versus no-poverty statusas information regarding income was missing for 70 individuals ∗∗P ≤ .05.
4.Results
4.1. 25(OH)D as a Categorical Variable. The overall preva-
lence of suspected NAFLD among adolescents was 8.39%
(weighted percentage). Serum ALT ≥ 30U/L was most
prevalent in subjects with the poorest 25(OH)D status.
In the bivariate analyses, suspected NAFLD was identiﬁed
in 12.31% of adolescents in the lowest quartile of serum
25(OH)D compared to 6.91% in the second quartile, 6.81%
of adolescent in the third quartile, and 7.14% of adolescents
in the fourth quartile (P = .05, Table 1). Additionally, male
adolescents were more likely to have suspected NAFLD than
females (males have a 13.70% of elevated ALT, while for
females, it is only 2.66%; P<. 001). Suspected NAFLD rates
increased with higher BMI: for normal-weight adolescents,
the prevalence of suspected NAFLD was 3.25, while for
overweight adolescents, the prevalence was 9.03% and
25.76% for obese adolescents. The prevalence of suspected
NAFLD varied by race/ethnicity with 11.63% for Mexican
Americans and 6.01% for Non-Hispanic Blacks (Table 1).
Age and poverty status were not signiﬁcantly associated with
suspected NAFLD.
Additionally, BMI status was taken out of the multi-
variate analyses investigating the independent association
between serum 25(OH)D and suspected NAFLD controlling
for age,gender,race,and poverty statusand it was foundthat
individuals with the lowest quartile of 25(OH)D levels had
signiﬁcantly higher rates of suspected NAFLD compared to
those in the fourth quartile (ﬁrst quartile versusfourth quar-
tile: OR: 2.44, 95% CI: 1.09–5.48). However, no signiﬁcant
association was found for those in the second versus those in
the fourth quartile (OR = 0.82, 95% CI: 0.32–2.06) or those
the in third versus those in the fourth quartile (OR = 0.83,
95% CI: 0.32–1.89).
Adjusted odds ratios (AOR) and 95% conﬁdence inter-
vals from multivariate analyses for the risk of suspected
NAFLD are shown in Table 2. Gender and BMI were
both signiﬁcantly independently associated with suspected
NAFLD (P<. 05). Adolescent males were 6.25 times
more likely than females to have suspected NAFLD (95%4 Journal of Obesity
Table 2: Factors associated with nonalcoholic fatty Liver disease (ALT ≥ 30) in multivariable analyses–NHANES 2001–2004: age 12–19,
n = 1560∗.
Odds Ratio Lower 95% Upper 95%
Age
12–15 y 1 1 1
16–19 y 1.61 0.92 2.82
Gender
Female 1 1 1
Male∗ 6.25 3.59 10.92
Race/ethnicity
Non-Hispanic White 1 1 1
Non-Hispanic Black 0.45 0.2 1.04
Mexican American 1.47 0.84 2.56
Other Hispanics 1.85 0.46 7.48
Other Races 0.88 0.27 2.86
BMI
Normal weight 1 1 1
Overweight 2.63 1.14 6.03
Obese∗ 11.57 5.93 22.6
Poverty status
No 1 1 1
Yes 1.54 0.92 2.57
25(OH)D quartile
I( ≤19ng/mL) 1.15 0.92 2.57
II (19ng/mL < serum[OH]D ≤ 25ng/mL) 0.48 0.51 2.55
III (25ng/mL < serum[OH]D ≤ 31ng/mL) 0.69 0.48 1.18
IV (≥ 31ng/mL) 1 1 1
Multiviate analyses without BMI∗∗
25(OH)D quartile
I( ≤19ng/mL)∗ 2.44 1.09 5.48
II (19ng/mL < serum[OH]D ≤ 25 ng/mL) 0.82 0.32 2.06
III (25ng/mL < serum[OH]D ≤ 31 ng/mL) 0.83 0.32 1.89
IV (≥ 31ng/mL) 1 1 1
N = 1560 because information was included in this model only for individuals with all of the relevant information regarding each variable.
∗Independently associated with NAFLD at P ≥ .05.
∗∗Separate multivariate analysis between 25(OH)D and ALT ≥ 30 controlling for age, gender, race, and poverty status.
CI 3.59–10.92). Obese adolescents were 11.57 times more
likely to have suspected NAFLD (95% CI 5.93–22.60) when
compared to normal-weight adolescents. In contrast, serum
25(OH)D was not independently associated with suspected
NAFLD in the multivariate model.
4.2. 25(OH)Das aContinuousVariable. Inbivariate analyses
treating vitamin D as a continuous variable, a lower mean
value of serum 25(OH)D was observed in subjects with
ALT ≥ 30 as compared to those with an ALT < 30. Mean
vitamin D was lower still among those with an ALT ≥ 40
when compared to those with ALT < 40. In contrast, there
was no diﬀerence in mean vitamin D level when individuals
with ALT levels below 20 were compared to those with
ALT levels ≥20 (Table 3). When both ALT and vitamin D
status were used as continuous, we found that with one unit
Table 3: Relationship between various ALT levels and 25(OH)D
assessed as a continuous variable, NHANES 2001–2004: age 12–19,
bivariate analyses (n = 1630).
N (unweighted) 25(OH)D mean (SE) P-value
ALT < 20 1118 25.09 (0.77) .1943
ALT > 20 512 25.94 (1.07)
ALT < 30 1487 25.58 (0.80) .0268
ALT > 30 143 23.01 (1.39)
ALT < 40 1564 25.50 (0.81) .0286
ALT > 40 66 22.13 (1.65)
of vitamin D increasing, there is likely 0.059 unit of ALT
decreasing (P = .045).Journal of Obesity 5
In bivariate analyses, waist circumference >90th per-
centile was signiﬁcantly associated (P<. 001) with suspected
NAFLD at all thresholds (ALT ≥ 20, 30 and 40) not shown.
Analyses were conducted to investigate potential interac-
tions between obesity and serum 25(OH)D and their rela-
tionship ALT ≥ 30. It was found that only obese adolescents,
irrespective of vitamin D status, were at increased risk for
elevated ALT (data not shown).
Also notshown in tablesare the following results treating
vitamin D as a continuous variable in the multivariate
models described in the Methods section. Vitamin D
was not independently associated with suspected NAFLD
in the multivariate analyses that included either BMI or
waist circumference. When the multivariate models did not
include either BMI or waist circumference variables, serum
25(OH)D levels were, however, signiﬁcantly associated with
suspected NAFLD as deﬁned by ALT ≥ 30 (OR: 0.96; 95%
CI: 0.92–0.99) and ALT ≥ 40 (OR: 0.93; 95% CI: 0.88–0.99).
5.Discussion
The ﬁndings of this study demonstrate that while serum
25(OH)D was inversely associated with ALT, this association
was abolished by adjusting for obesity as a confounding
factor. Thus, these ﬁndings do not indicate an independent
association between vitamin D status and suspected NAFLD,
as suggested by ALT level. This is true when vitamin D status
was assessed both categorically and as a continuous variable.
In contrast, increased BMI was consistently associated with
increased rates of ALT elevation.
It is well known that adolescents with obesity and its
comorbidities are at increased risk for developing NAFLD
[13] and that increased BMI is a signiﬁcant independent
predictor of hypovitaminosis D [17]. Low concentrations of
serum 25(OH)D found in overweight and obese adolescents
may reﬂect an inadequate diet or a more sedentary lifestyle
with less time spent outdoors, resulting in less sunlight
exposure [10, 17, 18]. It also is possible that lower serum
25(OH)D levels in heavier individuals reﬂect the sequestra-
tion of vitamin D in adipose tissue [19].
Other predictors of hypovitaminosis D in adolescents
may include ethnicity, season, latitude, and milk and juice
consumption [17, 20].
In the statistical models treating serum 25(OH)D as a
categorical variable, obesity and male gender were found to
be independently associated with suspected NAFLD; lower
levels of 25(OH)D were not found to be independently
associated with NAFLD after adjusting for confounding
variables including age, sex, race, BMI, and poverty level.
These results were conﬁrmed by treating 25(OH)D as a
continuous variable and assessing for three diﬀerent levels of
ALT,thatis, ≥20, ≥30,and ≥40U/L,aspotentialmeasuresof
NAFLD. The method of measuring adiposity (BMI or waist
circumference >90th percentile) did not aﬀect the results
of these multivariate analyses. Hypovitaminosis D was,
however, independently associated with suspected NAFLD
in the only multivariate model that did not include either
BMI or waist circumference. Considering that adiposity is
well documented as contributing to the risk of developing
NAFLD, these results suggest that it is obesity, rather than
vitaminDstatus,thatisinfactindependentlyassociatedwith
NAFLD.
There is currently a paucity of studies investigating
the relationship between vitamin D status and NAFLD in
adolescents. The ﬁndings reported here are consistent with
another study by Ashraf et al. [14]. Those authors found no
signiﬁcant diﬀerences in ALT or aspartate aminotransferase
(AST) when comparing adolescents with or without ade-
quate concentrations of serum 25(OH)D. Adequate serum
25(OH)D was deﬁned as a concentration greater than
15ng/ml. However, the study by Ashraf et al. was limited
to 51 African American female adolescents who were obese.
The current study includes a larger, nationally representative
sample of adolescents that more accurately reﬂect the USA
population. In contrast, a study by Targher et al. found, for
the ﬁrst time, that adults with biopsy-proven NAFLD had
higher rates of hypovitaminosis D than matched control
subjects [15]. Targher et al. observed an inverse relationship
between serum 25(OH)D and biopsy-determined diagnoses
of NAFLD, independent of insulin sensitivity and the
metabolic syndrome. However, that study involved a small
sample of only 60 adults and these results may not be
applicable to adolescents because adults may accumulate a
number of other insults to the liver over their lifespans. In
the pediatric population, another small study also identiﬁed
lower concentrations of serum 25(OH)D in children with
biopsy-proven nonalcoholic liver disease [16]. It also is
possible that 25-hydroxylation of vitamin D may be reduced
when there is preexisting liver damage, rather than that low
vitamin D levels lead to liver disease.
Racial and ethnic diﬀerences in rates of NAFLD have
been documented for some time in the USA [13, 21,
22]. Elevated ALT concentrations are more common in
Hispanic adolescents [23, 24]. In contrast, non-Hispanic
Blackadolescentshavea lowerprevalenceof NAFLD.During
1999–2004, rates of elevated ALT concentrations (>30U/L)
were 11.5% among Mexican American adolescents, 6.0%
amongBlackadolescents,and7.4%amongwhiteadolescents
[13]. The mechanisms underlying these diﬀerences are not
known, although Non-Hispanic Black adolescents have less
intraperitoneal fat and less lower extremity fat compared
to whites and Hispanics, and intraperitoneal fat has been
identiﬁed as a potential risk for liver damage at a young age
[13, 25].
5.1. Limitations. These data come from cross-sectional anal-
yses and thus have substantial limitations for drawing causal
inferences.
A deﬁnitive diagnosis of NAFLD requires a liver biopsy
which is not feasible in large-scale epidemiological studies
[11]. ALT is a widely accepted biomarker for liver fat
accumulation; however, it is neither as speciﬁc nor as sen-
sitive as biopsy. There is no consensus regarding a standard
threshold for elevated ALT, although previous values used
in the literature range from 20 to 40U/L [13, 26]. Future
studies may explore the correlation of vitamin D and liver6 Journal of Obesity
pathology using ultrasonography, as it is a valuable non-
invasive method of screening for liver disease [27, 28].
It also is well recognized that season exerts major
inﬂuences on cutaneous vitamin D3 production [29]. Pho-
tosynthesis of vitamin D is higher with more exposure to
UVB sunlight. Of note, a recent study of adults found higher
levels of most liver function tests in the winter, suggesting
that seasonal variation be taken into consideration when
establishing either reference intervals or cut-oﬀ values,
especially regarding aminotransferases [30].
Also, no data were available regarding alcohol consump-
tion in this sample. Future studies of adolescent NAFLD
should consider utilizing alcohol consumption as an exclu-
sion criterion. Oral contraceptives use has been associated
with higher serum 25(OH)D and also may be deserving of
investigation in future studies [31].
6.Conclusions
This study, like others before it, indicates that overweight
and obese adolescents are much more likely than normal-
weight adolescents to have elevated serum ALT, a surrogate
biomarker for NAFLD. It is unclear whether poor vitamin D
status contributes directly to the risk of developing NAFLD,
or if this association is overwhelmingly confounded by obe-
sity. This study examined the relationship between hypovita-
minosis D and suspected NAFLD and did not ﬁnd that low-
vitamin D status is an independent predictor of NAFLD.
Itis important for clinicianstoidentify andtreat children
with obesity and its comorbidities as early as possible [32].
In a prospective study, Forouhi et al. demonstrated that low-
vitamin D status is a predictor of future hyperglycemia and
insulin resistance [33]. Previous work has also found that
insulin sensitivity improvesaftervitamin Dsupplementation
[8, 9]. Therefore, further research is needed to determine if
vitamin D supplementation might be eﬀective in preventing
or treating NAFLD in obese adolescents.
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